These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31318308)

  • 1. Binding symmetry and surface flexibility mediate antibody self-association.
    Schrag JD; Picard MÈ; Gaudreault F; Gagnon LP; Baardsnes J; Manenda MS; Sheff J; Deprez C; Baptista C; Hogues H; Kelly JF; Purisima EO; Shi R; Sulea T
    MAbs; 2019 Oct; 11(7):1300-1318. PubMed ID: 31318308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange.
    Zhang A; Singh SK; Shirts MR; Kumar S; Fernandez EJ
    Pharm Res; 2012 Jan; 29(1):236-50. PubMed ID: 21805212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab Fragment.
    Zhang C; Samad M; Yu H; Chakroun N; Hilton D; Dalby PA
    Mol Pharm; 2018 Aug; 15(8):3079-3092. PubMed ID: 29897777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
    Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
    Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of potential sites for antibody engineering by fluctuation editing.
    Yanaka S; Moriwaki Y; Tsumoto K; Sugase K
    Sci Rep; 2017 Aug; 7(1):9597. PubMed ID: 28855581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering an anti-CD52 antibody for enhanced deamidation stability.
    Qiu H; Wei R; Jaworski J; Boudanova E; Hughes H; VanPatten S; Lund A; Day J; Zhou Y; McSherry T; Pan CQ; Sendak R
    MAbs; 2019 Oct; 11(7):1266-1275. PubMed ID: 31199181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water channel in the binding site of a high affinity anti-methotrexate antibody.
    Gayda S; Longenecker KL; Manoj S; Judge RA; Saldana SC; Ruan Q; Swift KM; Tetin SY
    Biochemistry; 2014 Jun; 53(23):3719-26. PubMed ID: 24832237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural evidence for a constrained conformation of short CDR-L3 in antibodies.
    Teplyakov A; Obmolova G; Malia TJ; Luo J; Gilliland GL
    Proteins; 2014 Aug; 82(8):1679-83. PubMed ID: 24470236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling enhancement of antibody fragment stability - Role of format structure and cysteine modification.
    Ma H; Ó'Fágáin C; O'Kennedy R
    J Immunol Methods; 2019 Jan; 464():57-63. PubMed ID: 30468735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
    Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
    Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
    MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions.
    Perchiacca JM; Bhattacharya M; Tessier PM
    Proteins; 2011 Sep; 79(9):2637-47. PubMed ID: 21732420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit.
    Zhou K; Cao X; Bautista J; Chen Z; Hershey N; Ludwig R; Tao L; Zeng M; Das TK
    J Pharm Sci; 2020 Jan; 109(1):422-428. PubMed ID: 31469998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues.
    Studnicka GM; Soares S; Better M; Williams RE; Nadell R; Horwitz AH
    Protein Eng; 1994 Jun; 7(6):805-14. PubMed ID: 7937712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fab MOR03268 triggers absorption shift of a diagnostic dye via packaging in a solvent-shielded Fab dimer interface.
    Hillig RC; Urlinger S; Fanghänel J; Brocks B; Haenel C; Stark Y; Sülzle D; Svergun DI; Baesler S; Malawski G; Moosmayer D; Menrad A; Schirner M; Licha K
    J Mol Biol; 2008 Mar; 377(1):206-19. PubMed ID: 18241888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
    Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
    Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.